Google DeepMind, BioNtech Unveil AI Lab Assistants To Revolutionize Scientific Research
Google DeepMind, BioNtech Unveil AI Lab Assistants To Revolutionize Scientific Research
Meanwhile, BioNTech and its AI subsidiary InstaDeep introduced an AI assistant named Laila, built on Meta's Llama 3.1 model. During a live demonstration, research scientist Google DeepMind by Alphabet Inc. (NASDAQ:GOOGL) (NASDAQ:GOOG) and BioNTech (NASDAQ:BNTX) are collaborating to develop AI lab assistants aimed at enhancing scientific research.
Alphabet Inc.（納斯達克股票代碼：GOOG）（納斯達克股票代碼：GOOG）旗下的谷歌DeepMind和BioNTech（納斯達克股票代碼：BNTX）正在合作開發旨在加強科學研究的人工智能實驗室助手。
What Happened: Sir Demis Hassabis, head of Google's AI division, is spearheading the creation of an AI model designed to function as a research assistant. This AI aims to facilitate interdisciplinary collaboration and uncover unexpected connections in scientific research, Financial Times reported on Wednesday.
發生了什麼：谷歌人工智能部門負責人戴米斯·哈薩比斯爵士正在帶頭創建一種旨在充當研究助理的人工智能模型。《金融時報》週三報道，這種人工智能旨在促進跨學科合作並發現科學研究中的意想不到的聯繫。
At a recent Nobel Foundation event, Hassabis highlighted the transformative impact of AI on biology, stating, "We're working on a science large language model that could be like a research assistant and maybe help you predict the outcome of an experiment."
在最近的一次諾貝爾基金會活動中，哈薩比斯強調了人工智能對生物學的變革性影響，他說：「我們正在研究一種大型科學語言模型，它可以像研究助理一樣，可以幫助你預測實驗的結果。」
Meanwhile, BioNTech and its AI subsidiary InstaDeep introduced an AI assistant named Laila, built on Meta's Llama 3.1 model. During a live demonstration, research scientist Arnu Pretorius showcased Laila's capabilities in automating routine tasks in experimental biology.
同時，BioNTech及其人工智能子公司InstaDeep推出了一款名爲Laila的人工智能助手，該助手基於Meta的Llama 3.1模型構建。在現場演示中，研究科學家阿努·普雷托里烏斯展示了萊拉在實驗生物學中自動化常規任務的能力。
InstaDeep's CEO Karim Beguir emphasized that AI agents like Laila are intended to boost productivity, allowing scientists to focus on critical tasks. The AI models presented by InstaDeep also aim to assist BioNTech in identifying new targets for cancer treatment.
InstaDeep的首席執行官卡里姆·貝吉爾強調，像萊拉這樣的人工智能代理旨在提高生產力，使科學家能夠專注於關鍵任務。InstaDeep提出的人工智能模型還旨在幫助BioNTech確定癌症治療的新靶標。
Why It Matters: Google DeepMind's shift from a research-centric entity to an AI product powerhouse is a significant development in the tech industry. This transition, reported in June, signifies a strategic pivot to commercial services, potentially disrupting traditional research paradigms.
爲何重要：谷歌DeepMind從以研究爲中心的實體向人工智能產品強國的轉變是科技行業的重大發展。6月份公佈的這一轉變標誌着戰略轉向商業服務，有可能顛覆傳統的研究模式。
In May, Google DeepMind introduced AlphaFold 3, an AI model capable of predicting the structure and interactions of biological molecules, including proteins and DNA. This model is available for non-commercial use, aiding scientists in disease research.
5月，谷歌DeepMind推出了AlphaFold 3，這是一款能夠預測包括蛋白質和DNA在內的生物分子的結構和相互作用的人工智能模型。該模型可用於非商業用途，可幫助科學家進行疾病研究。
On the other hand, BioNTech has faced financial challenges, reporting deeper losses in Q2 2024 due to reduced demand for its COVID-19 vaccine. The company has increased R&D spending on new cancer treatments, highlighting the importance of innovative solutions like AI to drive future growth.
另一方面，BioNTech面臨財務挑戰，報告稱，由於對其 COVID-19 疫苗的需求減少，2024年第二季度虧損更大。該公司增加了新癌症療法的研發支出，凸顯了人工智能等創新解決方案對推動未來增長的重要性。
Price Action: As per Benzinga Pro, GOOGL closed at $166.99 while GOOG ended at $168.42. BioNTech closed at $119.93.
價格走勢：根據Benzinga Pro的數據，谷歌收於166.99美元，而GOOG收於168.42美元。BioNTech收於119.93美元。
- CVS Health in Focus as Activist Investor Prepares for High-Level Talks
- 激進投資者爲高級別會談做準備之際，CVS 健康備受關注
Image via Shutterstock
圖片來自 Shutterstock
This story was generated using Benzinga Neuro and edited by Pooja Rajkumari
這個故事是使用 Benzinga Neuro 創作的，由 Pooja Rajkumari
